Literature DB >> 33481141

Lymphoma subtypes in India: a tertiary care center review.

Surabhi Jain1, Moien Rasheed Lone1, Ansh Goswami1, Trisha Mandal1, Arun K Panda1, Prashant Ramteke1, Tryambak Srivastav1, Mehar Chand Sharma1, Ajay Gogia2, Atul Sharma2, Sameer Bakhshi2, Manoranjan Mahapatra3, Lalit Kumar2, Saumyaranjan Mallick4.   

Abstract

Lymphomas are a group of neoplasm arising from immune cells with varied clinical presentation, molecular profile, morphology and immunophenotype. The epidemiology and response to treatment varies among patients from different geographical locations. We analyze the demographic characteristics of lymphomas in a tertiary care center of India over a period of five years. This was a retrospective study including cases from 2015 to 2019 which were classified according to WHO classification 2017. A total of 4115 lymphoma cases were diagnosed. Hodgkin lymphomas (HL) comprised 30.35% (n = 1249), and non-Hodgkin lymphoma (NHL) was 69.65% (n = 2866). Site of presentation was nodal in 64.76% cases, and 35.23% were extranodal. There was an overall male predominance. Among the NHLs, B-cell type comprised of 84.08% and 15.38% was T- and NK cell lymphomas. Mature B cell lymphomas comprised 82.41% with predominant being diffuse large B cell lymphoma type (42.53%) followed by follicular lymphoma (10.81%) and small lymphocytic lymphoma (6.10%). Among the T-cell type, PTCL NOS (2.65%) was the predominant subtype followed by ALK positive anaplastic large cell lymphoma (ALCL-ALK+) (2.44%), extranodal NK-T cell lymphoma (2.02%) and others. Classical type was predominant type (97.91%) among HL, and 2.08% were nodular lymphocyte predominant type. Among the classical HL, nodular sclerosis (28.1%) and mixed cellularity (32.18%) co-dominated. Our study indicates that the Indian population differs in the prevalence, presentation and the subtyping among various lymphomas. Higher prevalence of Hodgkin lymphoma, DLBCL, ALK + ALCL and immature cell neoplasm was noted.

Entities:  

Keywords:  HL; India; Lymphoma subtypes; NHL

Year:  2021        PMID: 33481141     DOI: 10.1007/s10238-021-00683-2

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  1 in total

1.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

  1 in total
  2 in total

Review 1.  Neoplasms of follicular helper T-cells: an insight into the pathobiology.

Authors:  Surabhi Jain; Saumyaranjan Mallick; Prashant Ramteke; Ajay Gogia
Journal:  Am J Blood Res       Date:  2022-06-20

2.  In silico and in vivo analysis of TIPE1 expression in diffuse large B cell lymphoma.

Authors:  Pei Shen; Xianjuan Shen; Guo Chen; Chunmei Zhao; Hua Cai; Xinxin Xu; Yinong Duan; Xudong Wang; Shaoqing Ju
Journal:  Open Life Sci       Date:  2022-08-30       Impact factor: 1.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.